Omics profiles of fecal and oral microbiota change in irritable bowel syndrome patients with diarrhea and symptom exacerbation

[1]  M. Surette,et al.  Gut Microbiota in Patients With Irritable Bowel Syndrome-A Systematic Review. , 2019, Gastroenterology.

[2]  Bingqiang Liu,et al.  MetaQUBIC: a computational pipeline for gene-level functional profiling of metagenome and metatranscriptome , 2019, Bioinform..

[3]  T. Abe,et al.  Gut microbiome-derived phenyl sulfate contributes to albuminuria in diabetic kidney disease , 2019, Nature Communications.

[4]  P. Moayyedi,et al.  Efficacy of pharmacological therapies in patients with IBS with diarrhoea or mixed stool pattern: systematic review and network meta-analysis , 2019, Gut.

[5]  M. Camilleri,et al.  Current Practice in the Diagnosis of Bile Acid Diarrhea. , 2019, Gastroenterology.

[6]  J. Raes,et al.  The neuroactive potential of the human gut microbiota in quality of life and depression , 2019, Nature Microbiology.

[7]  J. Lefante,et al.  Randomised placebo-controlled trial of dietary glutamine supplements for postinfectious irritable bowel syndrome , 2018, Gut.

[8]  Philip Strandwitz.  Neurotransmitter modulation by the gut microbiota , 2018, Brain Research.

[9]  N. Lang,et al.  Periodontal health , 2018, Journal of clinical periodontology.

[10]  K. Kornman,et al.  Staging and grading of periodontitis: Framework and proposal of a new classification and case definition , 2018, Journal of periodontology.

[11]  Xiang Gu,et al.  The effect of Clostridium butyricum on symptoms and fecal microbiota in diarrhea-dominant irritable bowel syndrome: a randomized, double-blind, placebo-controlled trial , 2018, Scientific Reports.

[12]  J. Segre,et al.  Ectopic colonization of oral bacteria in the intestine drives TH1 cell induction and inflammation , 2017, Science.

[13]  Johannes Söding,et al.  MMseqs2: sensitive protein sequence searching for the analysis of massive data sets , 2017, bioRxiv.

[14]  F. Shanahan,et al.  The oral microbiota in colorectal cancer is distinctive and predictive , 2017, Gut.

[15]  M. Surette,et al.  Probiotic Bifidobacterium longum NCC3001 Reduces Depression Scores and Alters Brain Activity: A Pilot Study in Patients With Irritable Bowel Syndrome. , 2017, Gastroenterology.

[16]  D. Ilstrup,et al.  A Double-blind, Placebo-Controlled Study , 2017 .

[17]  M. Kanehisa.  Enzyme Annotation and Metabolic Reconstruction Using KEGG. , 2017, Methods in molecular biology.

[18]  R. Mazzoli,et al.  The Neuro-endocrinological Role of Microbial Glutamate and GABA Signaling , 2016, Front. Microbiol..

[19]  Gunnar C. Hansson,et al.  Immunological aspects of intestinal mucus and mucins , 2016, Nature Reviews Immunology.

[20]  P. Dupont,et al.  Differential Activation in Amygdala and Plasma Noradrenaline during Colorectal Distention by Administration of Corticotropin-Releasing Hormone between Healthy Individuals and Patients with Irritable Bowel Syndrome , 2016, PloS one.

[21]  D. Drossman.  Functional Gastrointestinal Disorders: History, Pathophysiology, Clinical Features and Rome IV. , 2016, Gastroenterology.

[22]  B. Rahim-Williams,et al.  The microbiome of the oral mucosa in irritable bowel syndrome , 2016, Gut microbes.

[23]  R. Spiller,et al.  Irritable bowel syndrome , 2015, Nature Reviews Disease Primers.

[24]  W. Whitman.  Bergey's Manual of Systematics of Archaea and Bacteria , 2016 .

[25]  Xinghuan Wang,et al.  The impact of surgical treatments for lower urinary tract symptoms/benign prostatic hyperplasia on male erectile function , 2016, Medicine.

[26]  Qiang Feng,et al.  The oral and gut microbiomes are perturbed in rheumatoid arthritis and partly normalized after treatment , 2015, Nature Medicine.

[27]  F. D’Acquisto,et al.  Lactate Regulates Metabolic and Pro-inflammatory Circuits in Control of T Cell Migration and Effector Functions , 2015, PLoS biology.

[28]  Jeroen Raes,et al.  Stool consistency is strongly associated with gut microbiota richness and composition, enterotypes and bacterial growth rates , 2015, Gut.

[29]  Rustem F. Ismagilov,et al.  Indigenous Bacteria from the Gut Microbiota Regulate Host Serotonin Biosynthesis , 2015, Cell.

[30]  Kunihiko Sadakane,et al.  MEGAHIT: an ultra-fast single-node solution for large and complex metagenomics assembly via succinct de Bruijn graph , 2014, Bioinform..

[31]  L. Öhman,et al.  Crosstalk at the mucosal border: importance of the gut microenvironment in IBS , 2015, Nature Reviews Gastroenterology &Hepatology.

[32]  L. Ruiz,et al.  Bile resistance mechanisms in Lactobacillus and Bifidobacterium , 2013, Front. Microbiol..

[33]  P. Bork,et al.  Richness of human gut microbiome correlates with metabolic markers , 2013, Nature.

[34]  T. Dinan,et al.  Regulation of the brain-gut axis by group III metabotropic glutamate receptors. , 2013, European journal of pharmacology.

[35]  M. Tomita,et al.  Metabolic profiling reveals new serum biomarkers for differentiating diabetic nephropathy , 2012, Analytical and Bioanalytical Chemistry.

[36]  Günter P. Wagner,et al.  Measurement of mRNA abundance using RNA-seq data: RPKM measure is inconsistent among samples , 2012, Theory in Biosciences.

[37]  S. Fukudo.  Hypothalamic-Pituitary-Adrenal Axis in Gastrointestinal Physiology , 2012 .

[38]  Sebastian Tims,et al.  Global and deep molecular analysis of microbiota signatures in fecal samples from patients with irritable bowel syndrome. , 2011, Gastroenterology.

[39]  Olli Simell,et al.  Gut Microbiome Metagenomics Analysis Suggests a Functional Model for the Development of Autoimmunity for Type 1 Diabetes , 2011, PloS one.

[40]  Takafumi Hara,et al.  Short-chain fatty acids and ketones directly regulate sympathetic nervous system via G protein-coupled receptor 41 (GPR41) , 2011, Proceedings of the National Academy of Sciences.

[41]  D. Drossman,et al.  Biopsychosocial Model of Irritable Bowel Syndrome , 2011, Journal of neurogastroenterology and motility.

[42]  R. Spiller.  Targeting the 5-HT(3) receptor in the treatment of irritable bowel syndrome. , 2011, Current opinion in pharmacology.

[43]  Wen-Han Yu,et al.  The Human Oral Microbiome Database: a web accessible resource for investigating oral microbe taxonomic and genomic information , 2010, Database J. Biol. Databases Curation.

[44]  M. Borodovsky,et al.  Ab initio gene identification in metagenomic sequences , 2010, Nucleic acids research.

[45]  S. Fukudo,et al.  Altered profiles of intestinal microbiota and organic acids may be the origin of symptoms in irritable bowel syndrome , 2009, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

[46]  M. Tomita,et al.  Capillary electrophoresis mass spectrometry-based saliva metabolomics identified oral, breast and pancreatic cancer-specific profiles , 2009, Metabolomics.

[47]  Richard Durbin,et al.  Sequence analysis Fast and accurate short read alignment with Burrows – Wheeler transform , 2009 .

[48]  John A. Peters,et al.  The 5-HT3 receptor – the relationship between structure and function , 2009, Neuropharmacology.

[49]  Lin Chang,et al.  FUNCTIONAL BOWEL DISORDERS , 2018, The American Journal of Gastroenterology.

[50]  H. Flint,et al.  Impact of pH on Lactate Formation and Utilization by Human Fecal Microbial Communities , 2007, Applied and Environmental Microbiology.

[51]  D. Drossman,et al.  Validation of the Japanese version of the Rome II modular questionnaire and irritable bowel syndrome severity index , 2006, Journal of Gastroenterology.

[52]  K. Barrett,et al.  Probiotics and commensals reverse TNF-alpha- and IFN-gamma-induced dysfunction in human intestinal epithelial cells. , 2006, Gastroenterology.

[53]  K. Gwee,et al.  Melatonin improves bowel symptoms in female patients with irritable bowel syndrome: a double‐blind placebo‐controlled study , 2005, Alimentary pharmacology & therapeutics.

[54]  K. Ho,et al.  Melatonin improves abdominal pain in irritable bowel syndrome patients who have sleep disturbances: a randomised, double blind, placebo controlled study , 2005, Gut.

[55]  D. Savaiano,et al.  Modification of Colonic Fermentation by Bifidobacteria and pH In Vitro (Impact on Lactose Metabolism, Short-Chain Fatty Acid, and Lactate Production) , 1997, Digestive Diseases and Sciences.

[56]  K. Barrett,et al.  Probiotics and Commensals Reverse TNF-α– and IFN-γ–Induced Dysfunction in Human Intestinal Epithelial Cells , 2003 .

[57]  Yosuke Kawasaki,et al.  [Irritable bowel syndrome(IBS)]. , 2003, Ryoikibetsu shokogun shirizu.

[58]  S. Elsenbruch,et al.  Diarrhea- and constipation-predominant IBS patients differ in postprandial autonomic and cortisol responses , 2001, American Journal of Gastroenterology.

[59]  J. Galmiche,et al.  Butyrate inhibits inflammatory responses through NFkappaB inhibition: implications for Crohn's disease. , 2000, Gut.

[60]  G. Chrousos,et al.  Regulation of the promoter of the human corticotropin-releasing hormone gene in transfected human endometrial cells. , 1996, Neuroendocrinology.

[61]  W. Zung.  A SELF-RATING DEPRESSION SCALE. , 1965, Archives of general psychiatry.